National Health Investors Statistics
National Health Investors (WX6) Stock Statistics & Valuation Metrics
Total Valuation
National Health Investors has a market cap or net worth of EUR 2.80B. The enterprise value is EUR 3.89B.
- Market Cap
- EUR 2.80B
- Enterprise Value
- EUR 3.89B
Share Statistics
National Health Investors has 49,110,435 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 49,110,435
- Owned by Insiders
- 2.39%
- Owned by Institutions
- 79.84%
Financial Efficiency
National Health Investors’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 6.97%.
- Return on Equity (ROE)
- 0.09
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 6.97%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 11.83M
- Profits Per Employee
- 4.44M
- Employee Count
- 32
- Asset Turnover
- 0.14
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of National Health Investors is 4.42. National Health Investors’s PEG ratio is 0.01.
- PE Ratio
- 4.42
- PS Ratio
- 6.76
- PB Ratio
- 1.48
- Price to FCF
- 14.86
- Price to Operating Cash Flow
- 13.07
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, National Health Investors had revenue of 378.53M and earned 142.18M in profits. Earnings per share was 3.03.
- Revenue
- 378.53M
- Gross Profit
- 138.93M
- Operating Income
- 194.83M
- Pretax Income
- 140.79M
- Net Income
- 142.18M
- EBITDA
- 282.00M
- Earnings Per Share (EPS)
- 3.03
Cash Flow
In the last 12 months, operating cash flow was 236.24M and capital expenditures -28.15M, giving a free cash flow of 208.09M billion.
- Operating Cash Flow
- 236.24M
- Free Cash Flow
- 208.09M
- Free Cash Flow per Share
- 4.24
Dividends & Yields
National Health Investors pays an annual dividend of ―, resulting in a dividend yield of 5.79%
- Dividend Per Share
- ―
- Dividend Yield
- 5.79%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 6.73%
- Earnings Yield
- 22.59%
Stock Price Statistics
- Beta
- 0.05
- 52-Week Price Change
- -15.27%
- 50-Day Moving Average
- 57.90
- 200-Day Moving Average
- 63.48
- Relative Strength Index (RSI)
- 43.45
- Average Volume (3m)
- 235
Important Dates
National Health Investors upcoming earnings date is Feb 23, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 09, 2026
- Next Earnings Date
- Feb 23, 2027
- Ex-Dividend Date
- ―
Financial Position
National Health Investors as a current ratio of 2.48, with Debt / Equity ratio of 76.49%
- Current Ratio
- 2.48
- Quick Ratio
- 2.48
- Debt to Market Cap
- 0.33
- Net Debt to EBITDA
- 4.06
- Interest Coverage Ratio
- 3.40
Taxes
In the past 12 months, National Health Investors has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
National Health Investors EV to EBITDA ratio is 4.80, with an EV/FCF ratio of 19.65.
- EV to Sales
- 8.94
- EV to EBITDA
- 4.80
- EV to Free Cash Flow
- 19.65
- EV to Operating Cash Flow
- 17.31
Balance Sheet
National Health Investors has EUR 46.56M in cash and marketable securities with EUR 1.04B in debt, giving a net cash position of -EUR 997.50M billion.
- Cash & Marketable Securities
- EUR 46.56M
- Total Debt
- EUR 1.04B
- Net Cash
- -EUR 997.50M
- Net Cash Per Share
- -EUR 20.31
- Tangible Book Value Per Share
- EUR 42.97
Margins
Gross margin is 50.57%, with operating margin of 39.86%, and net profit margin of 152.55%.
- Gross Margin
- 50.57%
- Operating Margin
- 39.86%
- Pretax Margin
- 152.33%
- Net Profit Margin
- 152.55%
- EBITDA Margin
- 186.19%
- EBIT Margin
- 164.74%
Analyst Forecast
The average price target for National Health Investors is EUR 67.32, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 67.32
- Price Target Upside
- 21.29% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 5
- Revenue Growth Forecast
- 21.66%
- EPS Growth Forecast
- 326.52%
Scores
- Smart Score
- 6
- AI Score
- ―

